Specific Biomarkers for Lysosomal Storage Disorders
Enabling Diagnosis, Prediction and Therapy Monitoring
November 14, 2017
3 p.m. CEST
Specific Biomarkers for Lysosomal Storage Disorders: Enabling Diagnosis, Prediction and Therapy Monitoring
Interested in the latest innovations in metabolic disease diagnostics and assessing the effects of therapy? Do you want to learn more about biochemical genetic testing at CENTOGENE? Join this webinar to learn more about novel biomarkers for lysosomal storage disorders (LSDs).
An ideal biomarker plays an essential role in the early diagnosis, prediction and therapeutic monitoring of a specific disorder. Using a biomarker either as a diagnosis tool for lysosomal storage and other metabolic diseases, or in regular monitoring of the disease progression, can be of high clinical value for the patients. Biomarkers can be used as a measure of therapy efficacy and even as a guide for therapy dosage.
- Introduction to Biomarker development and analysis at CENTOGENE
- Methodology/technology in CENTOGENE Biochemistry/Biomarker development
- Comprehensive clinical reporting
Dr. Cozma studied Biochemistry and Ecology and Environment protection in Romania and […]
Watch Our CentoTalks on demand
Our interactive webinars that feature key developments in clinical diagnostics.